Connect with us

Medical Research

HempFusion Partakes in ValidCare CBD Study Research on Human Liver Health

David Renfrew



- Ad -

HempFusion has announced that it will soon participate and sponsor a special scientific study on ValidCare. The study will deal with pertinent questions, based on CBD products, which previously were raised on a Food and Drug Administration forum.

Indeed, ValidCare will conduct a study revolving on human trial, to determine if the regular use of CBD or the full-spectrum- based CBD isolate, can have adverse consequences on the human liver. HempFusion is among the ten reputable CBD companies that offered to participate and sponsor the ground-breaking study by ValidCare. ValidCare CEO, Patrick McCarthy recently stated:

“We are most excited that a reputable company like HempFusion has come out to be among the respected companies that will be participating in this important study. We are pleased to note that this company has a good track record in the virtues of regulatory compliance, consumer safety standards, and progressive leadership ideals.”

“This study is particularly unique since we are absorbing real-world consumer evidence that revolves around how consumers use CBD products, and how this affects their bodies and overall health. Moreover, we are particularly interested in how the consumption of CBD products essentially impacts on the human liver; yes, our business is primarily liver safety. It is our conviction that this kind of evidence is essential to the FDA, and that it can be utilized to shape the overall future policy.”

The Study Will Impact Future Policy

ValidCare says the study schedule might commence at the end of the year 2020 and that the aim is to complete the matter by the end of the year. It is expected that the data generated from the companies that conduct the study will address the FDA’s questions on CBD products. This scientific data is primarily considered as a third-party. The co-CEO of HempFusion, Jason Mitchell, concludes:

“We are truly proud that we are participants in the seminal study by ValidCare. We are happy that we have the privilege to assist in CBD-based scientific research and its advancement. Indeed, our company is established on the premise of consumer safety and regulatory compliance. Thus, by taking part in the study, we hope to establish the reputation of HempFusion as a global industry leader in matters to do with CBD.”

David Renfrew is just now beginning his journey at TOC but has found himself on the forefront of the Canadian cannabis culture and marijuana movement. Among being a vocal CBD advocate, Dave is also a politically active father, author, small business owner and fierce reader of fiction and non-fiction. While early, the strong research skills and truly gifted writing talent make David one of our top editors.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.